• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于种系 MSH2 突变和体细胞 MLH1 高甲基化导致 Lynch 综合征相关结肠癌的免疫反应“空斑”模式。

"Null pattern" of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation.

机构信息

Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

出版信息

Am J Surg Pathol. 2011 Dec;35(12):1902-5. doi: 10.1097/PAS.0b013e318237c6ab.

DOI:10.1097/PAS.0b013e318237c6ab
PMID:22067334
Abstract

Lynch syndrome accounts for approximately 3% of newly diagnosed colorectal cancers and is caused by germline defects in DNA mismatch repair genes. Screening of patients for Lynch syndrome can be done by immunohistochemical staining for a panel of mismatch repair proteins and/or DNA testing for microsatellite instability. We describe a unique "null" immunophenotype in a Lynch syndrome associated colon cancer in a 71-year-old woman who also had a personal history of ureteral cancer and a strong family history of various malignancies. Immunohistochemical stains for MLH1, MSH2, PMS2, and MSH6 were completely negative in the tumor cells, with positive staining in stromal and inflammatory cells. Mutation analysis using peripheral blood showed a germline G587R mutation in the MSH2 gene. Further testing revealed the tumor to be positive for MLH1 promoter hypermethylation. Normal colonic mucosa adjacent to the tumor was negative for MLH1 promoter methylation. The lack of immunostaining for any of the 4 DNA mismatch repair proteins in this extremely unusual case was, therefore, related to a germline MSH2 mutation and somatic MLH1 promoter hypermethylation.

摘要

林奇综合征约占新发结直肠癌的 3%,是由 DNA 错配修复基因的种系缺陷引起的。林奇综合征患者的筛查可通过免疫组化染色一组错配修复蛋白和/或微卫星不稳定性的 DNA 检测来完成。我们描述了一位 71 岁女性林奇综合征相关结肠癌的独特“缺失”免疫表型,该患者还患有输尿管癌个人史和多种恶性肿瘤的强烈家族史。肿瘤细胞中 MLH1、MSH2、PMS2 和 MSH6 的免疫组化染色完全为阴性,而间质和炎症细胞呈阳性染色。外周血突变分析显示 MSH2 基因存在种系 G587R 突变。进一步的检测显示肿瘤 MLH1 启动子呈高甲基化阳性。肿瘤旁正常结肠黏膜 MLH1 启动子甲基化阴性。在这种极其罕见的情况下,4 种 DNA 错配修复蛋白中的任何一种免疫染色缺失,因此与种系 MSH2 突变和体细胞 MLH1 启动子高甲基化有关。

相似文献

1
"Null pattern" of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation.由于种系 MSH2 突变和体细胞 MLH1 高甲基化导致 Lynch 综合征相关结肠癌的免疫反应“空斑”模式。
Am J Surg Pathol. 2011 Dec;35(12):1902-5. doi: 10.1097/PAS.0b013e318237c6ab.
2
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.MLH1基因的种系高甲基化和EPCAM基因的缺失是林奇综合征的常见病因。
Genes Chromosomes Cancer. 2009 Aug;48(8):737-44. doi: 10.1002/gcc.20678.
3
Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.斯洛文尼亚结直肠癌患者种系 MLH1、MSH2、MSH6 和 PMS2 基因突变的筛查:对林奇综合征人群特异性检测策略的影响。
Fam Cancer. 2009;8(4):421-9. doi: 10.1007/s10689-009-9258-4. Epub 2009 Jun 13.
4
[The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].[匈牙利一个遗传性非息肉病性结直肠癌家系的首次分子分析:一种新的错配修复基因MSH2种系突变]
Orv Hetil. 2005 May 15;146(20):1009-16.
5
Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.林奇综合征在子宫内膜癌中的普遍筛查:种系突变的频率及林奇样综合征患者的鉴定。
Hum Pathol. 2017 Dec;70:121-128. doi: 10.1016/j.humpath.2017.10.022. Epub 2017 Oct 28.
6
Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.对年轻子宫内膜癌女性林奇综合征患病率的前瞻性测定。
J Clin Oncol. 2007 Nov 20;25(33):5158-64. doi: 10.1200/JCO.2007.10.8597. Epub 2007 Oct 9.
7
Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.林奇综合征中并存的体细胞启动子高甲基化和致病性MLH1种系突变
J Pathol. 2008 Jan;214(1):10-6. doi: 10.1002/path.2263.
8
Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.林奇综合征恶性肿瘤的聚集,无DNA错配修复作用的证据。
Gynecol Oncol. 2008 Feb;108(2):438-44. doi: 10.1016/j.ygyno.2007.09.036. Epub 2007 Nov 26.
9
PMS2 involvement in patients suspected of Lynch syndrome.PMS2在疑似林奇综合征患者中的作用。
Genes Chromosomes Cancer. 2009 Apr;48(4):322-9. doi: 10.1002/gcc.20642.
10
Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.在诊断性活检上应用 DNA 错配修复免疫组化进行林奇综合征的术前诊断。
Dis Colon Rectum. 2011 Dec;54(12):1480-7. doi: 10.1097/DCR.0b013e318231db1f.

引用本文的文献

1
Immunohistochemical "null" pattern of all four mismatch repair proteins in Lynch syndrome-associated small bowel adenocarcinoma: a case report and comprehensive genomic profiling.林奇综合征相关小肠腺癌中四种错配修复蛋白的免疫组化“阴性”模式:一例报告及综合基因组分析
Virchows Arch. 2025 Sep 2. doi: 10.1007/s00428-025-04232-0.
2
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.错配修复蛋白缺失表达揭示林奇综合征相关癌症中的时间分子事件。
Diagnostics (Basel). 2024 Apr 24;14(9):888. doi: 10.3390/diagnostics14090888.
3
Promoter Methylation Could Be the Second Hit in Lynch Syndrome Carcinogenesis.
启动子甲基化可能是林奇综合征癌变过程中的第二次打击。
Genes (Basel). 2023 Nov 9;14(11):2060. doi: 10.3390/genes14112060.
4
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.帕博利珠单抗治疗复发性林奇样型与散发型微卫星不稳定型子宫内膜癌的 2 期评估。
Cancer. 2022 Mar 15;128(6):1206-1218. doi: 10.1002/cncr.34025. Epub 2021 Dec 7.
5
An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.15% 的错配修复缺陷型肿瘤会出现一种不常见的表型,与非结直肠癌和遗传综合征有关。
Mod Pathol. 2022 Mar;35(3):427-437. doi: 10.1038/s41379-021-00918-3. Epub 2021 Sep 20.
6
Unusual immunohistochemical "null" pattern of four mismatch repair proteins in gastric cancer: A case report.胃癌中四种错配修复蛋白异常的免疫组化“缺失”模式:一例报告
World J Clin Cases. 2021 Jul 26;9(21):6102-6109. doi: 10.12998/wjcc.v9.i21.6102.
7
MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.MLH1 启动子甲基化:你是否确定 MLH1 胚系突变不存在?关于一个新病例。
Fam Cancer. 2020 Jan;19(1):11-14. doi: 10.1007/s10689-019-00151-7. Epub 2019 Nov 19.
8
Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.采用肽核酸探针介导熔解曲线分析的微卫星不稳定性检测:一项比较研究。
BMC Cancer. 2018 Dec 4;18(1):1218. doi: 10.1186/s12885-018-5127-6.
9
Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.林奇综合征相关子宫内膜癌伴 MLH1 胚系突变和 MLH1 启动子高甲基化:病例报告及文献复习。
BMC Cancer. 2018 May 21;18(1):576. doi: 10.1186/s12885-018-4489-0.
10
Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.在伴有MLH1高甲基化和MSH2体细胞突变的结肠癌中错配修复蛋白的免疫组化无表型。
Fam Cancer. 2018 Apr;17(2):225-228. doi: 10.1007/s10689-017-0031-9.